These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30579634)

  • 1. A Child With Lymphangioma Due to Somatic Mutation in PIK3CA Successfully Treated With Everolimus.
    Park S; Kim SH; Youn SE; Lee ST; Kang HC
    Pediatr Neurol; 2019 Feb; 91():65-67. PubMed ID: 30579634
    [No Abstract]   [Full Text] [Related]  

  • 2. The difficulties and risks of surgical treatment of lymphangiomas in the cervicofacial region.
    Ng JW; Wong MK
    J Pediatr Surg; 1996 Oct; 31(10):1463-4. PubMed ID: 8906692
    [No Abstract]   [Full Text] [Related]  

  • 3. Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma.
    Efe N; Altas E; Mazlumoglu MR; Aktan B; Ucuncu H; Eren S; Oner F
    J Craniofac Surg; 2016 Oct; 27(7):1802-1803. PubMed ID: 27513783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro.
    Citi V; Del Re M; Martelli A; Calderone V; Breschi MC; Danesi R
    Cancer Chemother Pharmacol; 2018 Apr; 81(4):745-754. PubMed ID: 29476223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of lymphangioma with OK432 in children].
    Makowski A; Apanasiewicz A; Chilarski A
    Otolaryngol Pol; 2005; 59(5):723-9. PubMed ID: 16471191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.
    Wirtz ED; Hoshino D; Maldonado AT; Tyson DR; Weaver AM
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):543-9. PubMed ID: 25855885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local injection of bleomycin A5 in lymphangioma in children. Analysis of 100 cases].
    Jiang JP
    Zhonghua Wai Ke Za Zhi; 1989 Dec; 27(12):741-2, 781. PubMed ID: 2483986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma.
    Zhong PQ; Zhi FX; Li R; Xue JL; Shu GY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Aug; 86(2):139-44. PubMed ID: 9720086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
    Lim SM; Park HS; Kim S; Kim S; Ali SM; Greenbowe JR; Yang IS; Kwon NJ; Lee JL; Ryu MH; Ahn JH; Lee J; Lee MG; Kim HS; Kim H; Kim HR; Moon YW; Chung HC; Kim JH; Kang YK; Cho BC
    Oncotarget; 2016 Mar; 7(9):10547-56. PubMed ID: 26859683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (Picibanil).
    Brewis C; Pracy JP; Albert DM
    Clin Otolaryngol Allied Sci; 2000 Apr; 25(2):130-4. PubMed ID: 10816217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing of recurrent lymphangioma using OK-432.
    Mikhail M; Kennedy R; Cramer B; Smith T
    J Pediatr Surg; 1995 Aug; 30(8):1159-60. PubMed ID: 7472972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities.
    Kondo N; Tsukuda M; Taguchi T; Nakazaki K; Sakakibara A; Takahashi H; Toth G; Nishimura G
    Cancer Sci; 2011 Sep; 102(9):1717-23. PubMed ID: 21631644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the successful treatment of lymphangioma with OK-432.
    Banieghbal B; Davies MR
    Eur J Pediatr Surg; 2003 Apr; 13(2):103-7. PubMed ID: 12776241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer.
    Nichols AC; Black M; Yoo J; Pinto N; Fernandes A; Haibe-Kains B; Boutros PC; Barrett JW
    BMC Pharmacol Toxicol; 2014 Nov; 15():66. PubMed ID: 25428177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OK-432 (Picibanil) therapy for lymphangiomas in children.
    Laranne J; Keski-Nisula L; Rautio R; Rautiainen M; Airaksinen M
    Eur Arch Otorhinolaryngol; 2002 May; 259(5):274-8. PubMed ID: 12107533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OK-432 therapy of lymphangiomas in children.
    Schmidt B; Schimpl G; Höllwarth ME
    Eur J Pediatr; 1996 Aug; 155(8):649-52. PubMed ID: 8839717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of neck lymphangioma with intralesional injection of bleomycin.
    Zulfiqar MA; Zaleha AM; Zakaria Z; Amin T
    Med J Malaysia; 1999 Dec; 54(4):478-81. PubMed ID: 11072465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local bleomycin injection in the treatment of lymphangioma.
    Baskin D; Tander B; Bankaoğlu M
    Eur J Pediatr Surg; 2005 Dec; 15(6):383-6. PubMed ID: 16418953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined sclerotherapy and surgery for huge cervical lymphangioma].
    Steiner Z; Pressman A; Mogilner J
    Harefuah; 1999 May; 136(10):779-81, 843, 842. PubMed ID: 10955112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enlarging cystic lymphangioma of the mediastinum in an adult: is this a neoplastic lesion related to the recently discovered PIK3CA mutation?
    Tajima S; Takanashi Y; Koda K
    Int J Clin Exp Pathol; 2015; 8(5):5924-8. PubMed ID: 26191320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.